Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
BMC Res Notes ; 10(1): 192, 2017 Jun 05.
Article in English | MEDLINE | ID: mdl-28583187

ABSTRACT

BACKGROUND: Shigella is an important cause of bacterial gastroenteritis in resource-poor countries. The treatment of shigellosis mostly requires antibiotics. However, the increase of multidrug resistance along with emergence of extended-spectrum ß-lactamase and ciprofloxacin resistance among Shigella spp. has challenged the situation. This study was conducted to determine the distribution of species and antibiotic susceptibility pattern of Shigella species isolated from stool specimen among children less than 5 years of age in Nepal. RESULTS: Out of total 717 stool samples collected, 15 cases of Shigella spp. was isolated which includes 12 S. flexneri and 3 S. sonnei. Multidrug resistance was found among 13(86%) of the isolates. One of the isolates of S. flexneri was found to be ESBL-producer with MIC >256 mg/L for cefixime. CONCLUSION: The high occurrence of multidrug resistance among Shigella spp. along with a case of ESBL-production for the first time in Nepal alarms the concerns about dissemination of the resistant isolates. So, systemic monitoring of the antimicrobial susceptibility pattern of Shigella spp. is becoming crucial to guide therapy.


Subject(s)
Anti-Infective Agents/therapeutic use , Dysentery, Bacillary/drug therapy , Shigella/drug effects , Tertiary Care Centers , Cefixime/therapeutic use , Child , Child, Preschool , Ciprofloxacin/therapeutic use , Drug Resistance, Multiple , Dysentery, Bacillary/microbiology , Feces/microbiology , Humans , Infant , Microbial Sensitivity Tests , Nepal , Shigella/enzymology , Shigella/physiology , beta-Lactamases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL